Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Poor Circulation: How to Prevent It, How to Spot It
SUNDAY, Oct. 6, 2024 — Pain, tingling and cramps in your legs and feet may be giving you a warning. They could be signs of poor blood circulation, which...
What You Need to Know After a Breast Cancer Diagnosis
SATURDAY, Oct. 5, 2024 -- Breast cancer strikes 1 in 8 women in the United States, but being diagnosed with the disease can still make you feel alone. To cope...
2021 USPSTF Recommendation Boosted Colorectal Cancer Screening
FRIDAY, Oct. 4, 2024 -- Uptake of colorectal cancer (CRC) screening increased after the 2021 U.S. Preventive Services Task Force (USPSTF) recommendation that...
Bright Light Therapy Effective for Nonseasonal Depressive Disorders
FRIDAY, Oct. 4, 2024 -- Bright light therapy (BLT) is an effective adjunctive treatment for nonseasonal depressive disorder, according to a review published...
Immunity From Mpox Vaccine May Be Waning
FRIDAY, Oct. 4, 2024 -- Immunity against mpox may be waning for those vaccinated with the modified vaccinia Ankara-Bavarian Nordic (MVA-BN; Jynneos) vaccine...
One in Nine Primary Care Visits Is for a Mental Health Issue
FRIDAY, Oct. 4, 2024 -- One in nine primary care visits is for a mental health condition, according to a study published online Sept. 19 in Nature Mental...
Fear of Cancer Recurrence Common Decades After Surviving Childhood Cancer
FRIDAY, Oct. 4, 2024 -- A third of childhood cancer survivors experience fear of recurrence even decades later, according to a study published online Oct. 3 in...
Hospital Drug Tests Far More Likely for Minority Teens
FRIDAY, Oct. 4, 2024 -- Teens from minority groups seeking treatment at pediatric trauma centers are more likely than their white counterparts to be tested for...
Water Fluoridation May Be Less Beneficial Than in Past, Review Finds
FRIDAY, Oct. 4, 2024 -- The health benefits of fluoridated drinking water may be waning as Americans increasingly turn to using toothpastes and mouthwashes...
California Reports Two Cases of Bird Flu in Dairy Workers, a First for the State
FRIDAY, Oct. 4, 2024 -- As an outbreak of bird flu among dairy cows continues to spread in the United States, two more cases have been reported in dairy...
Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
LEXINGTON, Mass.--(BUSINESS WIRE)--Oct. 3, 2024-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and...
U.S. Food and Drug Administration Approves Perioperative Treatment of Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Single-Agent Opdivo for Resectable Non-Small Cell Lung Cancer (NSCLC)
PRINCETON, N.J.--(BUSINESS WIRE) Oct 03, 2024 -- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved...
FDA Approves Otulfi (ustekinumab-aauz), a Biosimilar to Stelara
September 30, 2024 -- Fresenius Kabi, an operating company of Fresenius, specializing in biopharmaceuticals, clinical nutrition, medical technologies, and I.V...
Dupixent Approved in the US as the First-Ever Biologic Medicine for Patients with COPD
Paris and Tarrytown, NY, September 27, 2024. The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment of...
FDA Approves Flyrcado (flurpiridaz F 18) Radioactive Diagnostic for Enhanced Diagnosis of Coronary Artery Disease
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE) September 27, 2024 --GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Approves Cobenfy (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults
PRINCETON, N.J.--(BUSINESS WIRE)--26 September 2024-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has...
Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Boosted by CARES-310 Leading Overall Survival Analysis
FORT LEE, NEW JERSEY, Sept. 23, 2024 – Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd., today announced the resubmission of a New...
FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis
WASHINGTON, Sept. 19, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provided an update on its tradipitant development...
Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine
NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies...
KalVista Announces FDA Acceptance of New Drug Application for Sebetralstat for Oral On-Demand Treatment of Hereditary Angioedema
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S. Food...
Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program
NEW HAVEN, Conn., Oct. 3, 2024. Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio (oral...
ERLEADA demonstrates statistically significant and clinically meaningful improvement in overall survival compared to enzalutamide in patients with metastatic castration-sensitive prostate cancer
LISBON, Portugal, Oct. 2, 2024. Johnson & Johnson today announced the results of a landmark real-world, head-to-head study showing that ERLEADA...
Gilead Signs Royalty-Free Voluntary Licensing Agreements with Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countries
Foster City, Calif. – October 2, 2024 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has signed non-exclusive, royalty-free...
Eirion Therapeutics Announces Results of First-in-Human Clinical Trial Evaluating Ready-to-Use Liquid Injectable Neuromodulator AI-09 for the Treatment of Wrinkles
WOBURN, Mass., Oct. 1, 2024. Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings...
Sagimet Receives FDA Breakthrough Therapy Designation for Denifanstat in MASH
SAN MATEO, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Disclaimer
This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.